Crossref journal-article
Elsevier BV
Molecular Therapy (78)
Bibliography

Campos, S. K., Parrott, M. B., & Barry, M. A. (2004). Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. Molecular Therapy, 9(6), 942–954.

Authors 3
  1. Samuel K. Campos (first)
  2. M.Brandon Parrott (additional)
  3. Michael A. Barry (additional)
References 38 Referenced 78
  1. 10.1128/JVI.73.7.6182-6187.1999 / J. Virol. / The subgenus-specific C-terminal region of protein IX is located on the surface of the adenovirus capsid by Akalu (1999)
  2. 10.1517/14712598.3.6.925 / Expert Opin. Biol. Ther. / Biotinylated gene therapy vectors by Barry (2003)
  3. 10.1128/JVI.76.17.8621-8631.2002 / J. Virol. / Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein by Belousova (2002)
  4. 10.1126/science.275.5304.1320 / Science / Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5 by Bergelson (1997)
  5. 10.1073/pnas.120163297 / Proc. Natl. Acad. Sci. USA / One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products by Datsenko (2000)
  6. 10.1128/JVI.72.12.9706-9713.1998 / J. Virol. / An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism by Dmitriev (1998)
  7. 10.1128/JVI.76.14.6893-6899.2002 / J. Virol. / Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX by Dmitriev (2002)
  8. 10.1002/j.1460-2075.1989.tb08528.x / EMBO J. / Adenovirus polypeptide IX revealed as capsid cement by difference images from electron microscopy and crystallography by Furcinitti (1989)
  9. 10.1002/j.1460-2075.1987.tb02425.x / EMBO J. / Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes by Ghosh-Choudhury (1987)
  10. 10.1002/(SICI)1099-1654(1998100)8:4<213::AID-RMV225>3.0.CO;2-W / Rev. Med. Virol. / Virus assembly and disassembly: the adenovirus cysteine protease as a trigger factor by Greber (1998)
  11. 10.1016/0092-8674(93)90382-Z / Cell / Stepwise dismantling of adenovirus 2 during entry into cells by Greber (1993)
  12. 10.1073/pnas.95.5.2509 / Proc. Natl. Acad. Sci. USA / A simplified system for generating recombinant adenoviruses by He (1998)
  13. 10.1002/med.10008 / Med. Res. Rev. / Transferrin/transferrin receptor-mediated drug delivery by Li (2002)
  14. 10.1016/j.addr.2003.07.010 / Adv. Drug Delivery Rev. / Endocytosis of adenovirus and adenovirus capsid proteins by Medina-Kauwe (2003)
  15. 10.1128/JVI.74.15.7085-7095.2000 / J. Virol. / The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol by Nakano (2000)
  16. 10.1006/viro.2002.1510 / Virology / Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery by Pandori (2002)
  17. 10.1016/S1525-0016(03)00213-2 / Mol. Ther. / Metabolically biotinylated adenovirus for cell-targeting, ligand screening, and vector purification by Parrott (2003)
  18. 10.1006/mthe.1999.0011 / Mol. Ther. / Metabolic biotinylation of recombinant proteins in mammalian cells and in mice by Parrott (2000)
  19. 10.1006/bbrc.2001.4437 / Biochem. Biophys. Res. Commun. / Metabolic biotinylation of secreted and cell surface proteins from mammalian cells by Parrott (2001)
  20. {'key': '10.1016/j.ymthe.2004.03.006_BIB20', 'first-page': '9', 'article-title': 'What makes the bacteriophage λ Red system useful for genetic engineering: molecular mechanism and biological function', 'volume': '201', 'author': 'Poteete', 'year': '2001', 'journal-title': 'FEMS'} / FEMS / What makes the bacteriophage λ Red system useful for genetic engineering: molecular mechanism and biological function by Poteete (2001)
  21. 10.1124/pr.54.4.561 / Pharmacol. Rev. / Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway by Qian (2002)
  22. 10.1021/bi9925367 / Biochemistry / High resolution structure of the 1.3S subunit of transcarboxylase from Propionibacterium shermanii by Reddy (2000)
  23. 10.1038/sj.gt.3300941 / Gene Ther. / Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector by Reynolds (1999)
  24. 10.1128/JVI.75.15.7131-7141.2001 / J. Virol. / Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization by Rosa-Calatrava (2001)
  25. 10.1038/sj.gt.3301624 / Gene Ther. / Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo by Scherer (2002)
  26. {'key': '10.1016/j.ymthe.2004.03.006_BIB26', 'volume': 'Vol. 2, 4th ed.', 'author': 'Shenk', 'year': '2001'} by Shenk (2001)
  27. 10.1073/pnas.96.16.8855 / Proc. Natl. Acad. Sci. USA / Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens by Smith (1999)
  28. 10.1006/mthe.2002.0613 / Mol. Ther. / In vivo hepatic adenoviral gene delivery occurs independent of the coxsackievirus–adenovirus receptor by Smith (2002)
  29. 10.1089/104303403765255165 / Hum. Gene Ther. / Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice by Smith (2003)
  30. 10.1016/0092-8674(91)90578-M / Cell / Image reconstruction reveals the complex molecular organization of adenovirus by Stewart (1991)
  31. 10.1034/j.1600-0854.2003.00094.x / Traffic / Non-classical export of an adenovirus structural protein by Trotman (2003)
  32. 10.1128/JVI.56.2.439-448.1985 / J. Virol. / Molecular composition of the adenovirus type 2 virion by van Oostrum (1985)
  33. 10.1128/JVI.73.6.5156-5161.1999 / J. Virol. / RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection by Vigne (1999)
  34. 10.1016/S0092-8674(02)00912-1 / Cell / Adenovirus fiber disrupts CAR-mediated intercellular adhesion allowing virus escape by Walters (2002)
  35. 10.1016/0092-8674(93)90231-E / Cell / Integrins αvβ3 and αvβ5 promote adenovirus internalization but not adenovirus attachment by Wickham (1993)
  36. 10.1128/JVI.70.10.6831-6838.1996 / J. Virol. / Targeted adenovirus gene transfer to endothelial and smooth muscle cells using bispecific antibodies by Wickham (1996)
  37. 10.1128/JVI.71.11.8221-8229.1997 / J. Virol. / Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins by Wickham (1997)
  38. 10.1016/j.addr.2003.07.004 / Adv. Drug Delivery Rev. / Mechanisms of TfR-mediated transcytosis and sorting in epithelial cells and applications toward drug delivery by Widera (2003)
Dates
Type When
Created 21 years, 4 months ago (April 28, 2004, 8:31 a.m.)
Deposited 5 years, 5 months ago (April 1, 2020, 5:17 p.m.)
Indexed 4 months, 3 weeks ago (April 11, 2025, 7:49 a.m.)
Issued 21 years, 3 months ago (June 1, 2004)
Published 21 years, 3 months ago (June 1, 2004)
Published Print 21 years, 3 months ago (June 1, 2004)
Funders 0

None

@article{Campos_2004, title={Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector}, volume={9}, ISSN={1525-0016}, url={http://dx.doi.org/10.1016/j.ymthe.2004.03.006}, DOI={10.1016/j.ymthe.2004.03.006}, number={6}, journal={Molecular Therapy}, publisher={Elsevier BV}, author={Campos, Samuel K. and Parrott, M.Brandon and Barry, Michael A.}, year={2004}, month=jun, pages={942–954} }